Lead sponsor
Adrian Vella
6 GLP-1 and incretin trials led. Source: ClinicalTrials.gov, as of July 6, 2026.
6
Trials led
0
Ongoing
98
Total enrollment
3
Sites
Distinct sites across this sponsor's lead trials. A site running several of them counts once, matching the map. Total enrollment sums each trial's reported enrollment, whether planned or actual.
Portfolio
How this sponsor's trials break down
Trials by phase
Early Phase 1
2
Phase 1
1
Phase 3
3
Trials by status
Completed
6
Trials led
TrialEligibility highlightPhaseStatusEnrollment
Endogenous GLP-1 Secretion on Islet Function in People With and Without Type 2 Diabetes-Ph 3Completed23
A Study to Evaluate the Effect of Genetic Variation on Beta-cell Function During Fasting and Hyperglycemia in Nondiabetics-Ph 3Completed21
The Contribution of Incretin Hormones to Post-prandial Glucose Metabolism After Roux-en-Y Gastric BypassHealthy volunteersEarly Ph 1Completed20